Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2024
September 20, 2024 16:15 ET
|
Universe Pharmaceuticals INC.
JI’AN, Jiangxi, China, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (the “Company,” “we,” “our” and “us”) (Nasdaq: UPC), a pharmaceutical producer and distributor in China, today...
EverCommerce Announces Changes to Its Board Of Directors
September 20, 2024 16:15 ET
|
EverCommerce Inc.
DENVER, Sept. 20, 2024 (GLOBE NEWSWIRE) -- EverCommerce Inc. (Nasdaq: EVCM) (the “Company”), a leading provider of SaaS solutions for service SMBs, announced today the appointment of Alexi Wellman...
Mondelēz International to Acquire Evirth, a China Leader in Fast-Growing Cakes and Pastries
September 20, 2024 16:05 ET
|
Mondelez International, Inc.
Significantly expands Mondelēz investment in a China category leader for frozen-to-chilled cakes and pastriesMeets rising demand for fresh, premium offerings – especially among younger consumers in...
Middlesex Water Vice President G. Christian Andreasen to Participate in Upcoming Gabelli Funds PFAS Symposium
September 20, 2024 16:05 ET
|
Middlesex Water Company
MIDDLESEX WATER COMPANY VICE PRESIDENT G. CHRISTIAN ANDREASEN TO PARTICIPATE IN UPCOMING GABELLI FUNDS PFAS SYMPOSIUM ON SEPTEMBER 20, 2024
Haoxi Health Technology Limited Announces the Closing of a $12 Million Underwritten Follow-on Public Offering
September 20, 2024 16:05 ET
|
Haoxi Health Technology Limited
BEIJING, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Haoxi Health Technology Limited (the “Company” or “HAO”), an online marketing solution provider headquartered in Beijing, China, today announced that it...
Churchill Downs Incorporated 2024 Third Quarter Financial Results Conference Call Invitation
September 20, 2024 16:01 ET
|
Churchill Downs Incorporated
LOUISVILLE, Ky., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Churchill Downs Incorporated (“CDI” or “the Company”) announced today that the Company will release third quarter 2024 financial results after the...
Sutro Biopharma Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
September 20, 2024 16:01 ET
|
Sutro Biopharma, Inc.
SOUTH SAN FRANCISCO, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical-stage oncology company pioneering site-specific and...
Gaxos.ai Inc. Announces Exercise of Warrants for $3.24 Million Gross Proceeds
September 20, 2024 14:58 ET
|
GAXOS.AI INC.
Roseland, NJ, Sept. 20, 2024 (GLOBE NEWSWIRE) -- Gaxos.ai Inc. (NASDAQ: GXAI), (“Gaxos” or the “Company”), a company developing artificial intelligence applications across various sectors, today...
Longevity Biomedical, Inc. and FutureTech II Acquisition Corp. Announce Business Combination to Create Nasdaq-Listed Biopharmaceutical Company Focused on Advancing New Technologies to Promote Human Health and Longevity
September 20, 2024 14:55 ET
|
FutureTech II Acquisition Corp.
-Longevity Biomedical, Inc. is focused on developing and acquiring new technologies spanning therapeutics, health monitoring and digital health solutions to become a leading provider of...
Zevra Therapeutics’ MIPLYFFA™ (arimoclomol) Receives U.S. FDA Approval as Treatment for Niemann-Pick Disease Type C
September 20, 2024 12:08 ET
|
Zevra Therapeutics
MIPLYFFA is the first FDA-approved treatment for Niemann-Pick disease type C (NPC), an ultra-rare and progressive neurodegenerative diseaseMIPLYFFA is indicated for use in combination with miglustat...